Medical Marijuana for Crohn's Disease in Washington State

Crohn's disease is a chronic inflammatory bowel disease (IBD) that can cause severe abdominal pain, diarrhea, fatigue, and weight loss. Washington State explicitly recognizes Crohn's disease as a qualifying condition for medical marijuana — and for many patients with IBD, cannabis provides relief where conventional medications fall short.

Does Crohn's disease qualify for Washington medical marijuana?

Yes. Washington's medical cannabis statute (RCW 69.51A) lists Crohn's disease by name as a qualifying condition. Ulcerative colitis and other inflammatory bowel conditions may also qualify under the statute's broader "terminal or debilitating condition" language when they significantly impair daily functioning.

How cannabis helps with Crohn's symptoms

The gastrointestinal tract contains one of the highest concentrations of cannabinoid receptors in the body. This is why cannabis can have such pronounced effects on GI function:

• Pain relief — abdominal cramping and pain are common Crohn's symptoms. Cannabis reduces pain signal transmission through CB1 receptors in gut neurons and the brain.
• Reduced GI motility — THC slows intestinal transit, which can reduce urgency, frequency, and cramping in patients with diarrhea-predominant Crohn's
• Anti-inflammatory effects — CBD and THC both have anti-inflammatory properties. Animal studies show cannabinoids can reduce gut inflammation, though clinical trials in humans show mixed results on endoscopic remission
• Appetite stimulation — Crohn's patients often struggle with appetite and weight maintenance; THC is an effective appetite stimulant
• Nausea control — nausea is common during Crohn's flares and with some IBD medications; cannabis is well-established for nausea management
• Anxiety and stress reduction — Crohn's flares are often triggered or worsened by stress; cannabis can address the anxiety-IBD cycle

A 2013 study in Clinical Gastroenterology and Hepatology found that 45% of Crohn's patients achieved complete remission with cannabis use vs. 10% with placebo. Note: "complete remission" in this context was clinical (symptom-based) remission, not endoscopic remission — cannabis appears to help symptoms more than it reduces underlying gut inflammation at the mucosal level.

Important considerations for Crohn's patients

• Smoking vs. other delivery methods — smoking can irritate the GI tract. Oral forms (capsules, tinctures, edibles) and vaporization are generally preferred for IBD patients
• Interaction with Crohn's medications — cannabis generally has a low interaction profile with common IBD biologics (adalimumab, infliximab, ustekinumab), but may interact with immunosuppressants metabolized by CYP450 enzymes. Share your medication list with your provider
• Flare vs. maintenance use — some patients use cannabis primarily during flares; others find daily low-dose use more effective for maintaining remission. Your provider can help you think through the approach

Getting your authorization

Bringing documentation of your Crohn's diagnosis (a GI specialist letter, colonoscopy report, or medication list showing biologics or immunosuppressants) is helpful but not required. Green Wellness providers are familiar with IBD and can have an informed conversation about your specific situation.

Same-day appointments available at Lynnwood, Spokane, Olympia, and Vancouver. Telehealth for renewals.

Book your Crohn's evaluation — $175 →